Google
Trusted Resources: News & Events
Latest announcements and gatherings
The Brain + Executive Function in Sickle Cell Disease: Part 1- A Neuropsychology Perspective
November 21, 2020
11 AM – 1:30 PM PST
Through 3 separate talks, this seminar series will focus on the medical (neurological/developmental), neuropsychological, behavioral, and educational aspects of the neurocognitive complications of sickle cell disease to raise awareness in patients and providers about these challenges.
Our goal is to help raise awareness about the neurocognitive challenges associated with sickle cell disease so that patients, parents, and their families will be able to recognize these issues earlier in life, actively discuss their concerns with their providers in an informed manner, and advocate for necessary treatments and services.
You will learn:
- The role of executive function in child and adult development
- Why and how sickle cell disease can impact executive function
- Diagnostic and treatment options available for executive dysfunction
- Cognitive challenges associated with sickle cell disease, such as ADHD, learning disabilities, and language disorders
We look forward to having you join us during these mini-seminars. Mark your calendars for the others taking place in 2021:
- Saturday, March 20, 2021 from 11 am – 1:30 pm PST
- Saturday, May 22, 2021 from 11 am – 1 pm PST
This event has ended.
+myBinderRelated Content
-
Martin H. Steinberg, MDDr. Steinberg is currently working as pr...
-
Is Caregiver Education About Sickle Cell Trait Effective?Despite universal newborn screening that...
-
Piracetam for reducing the incidence of painful sickle cell disease crisesBACKGROUND: Sickle cell disease is one ...
-
Lifespan Comprehensive Sickle Cell CenterThe Lifespan Comprehensive Sickle Cell C...
-
Wally Smith, MDWally Smith is Professor of Internal Med...
-
Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and...BACKGROUND/AIMS: Neuropathic pain is a k...
-
Sancilio Pharmaceuticals Company, Inc. Announces Completion of Enrollment in the SCOT Trial in Pediatric Patients Wi...Sancilio Pharmaceuticals Company, Inc. (...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.